Questionnaire of the Section Perioperative Intensive Care of the European Society of Intensive Care Medicine (ESICM) on Standardized Drug Labelling

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Claudia Spies, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01232088
First received: November 1, 2010
Last updated: September 7, 2011
Last verified: September 2011
  Purpose

Medication errors are common in intensive care (Valentin A et al., BMJ. 2009;338). Standardized color coded labels for user applied syringes enjoy strong support from many health professionals, thinking that this might increase patient safety. Whether this is true or not warrants further research.


Condition
Drug Labelling

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Questionnaire of the Section Perioperative Intensive Care of the European Society of Intensive Care Medicine (ESICM) on Standardized Drug Labelling

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • The primary objective is to assess if standardized drug syringe labelling is used in European ICUs. [ Time Frame: A period of 90 days. ] [ Designated as safety issue: No ]
    Online survey for ICU physicians (members of the ESICM).


Secondary Outcome Measures:
  • The second objectives is to assess 1. if standards for drug syringe labelling are similar in European ICUs and 2. if users expect that standardized drug syringe labelling should be delivered by the pharmaceutical industry. [ Time Frame: A period of 90 days ] [ Designated as safety issue: No ]
    Online survey for ICU physicians (members of the ESICM).


Enrollment: 482
Study Start Date: November 2010
Study Completion Date: September 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Data collection group: ICU physicians
Online survey for ICU physicians (members of the European Society of Intensive Care Medicine (ESICM)).

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Members of the European Society of Intensive Care Medicine (ESICM)

Criteria

Inclusion Criteria:

Members of the European Society of Intensive Care Medicine (ESICM)

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01232088

Locations
Germany
Department of Anesthesiology and Intensive Care Medicine Campus Virchow Klinikum/Campus Charité Mitte
Berlin, Germany, 13353/10117
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Claudia Spies, Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charite University, Berlin, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01232088     History of Changes
Other Study ID Numbers: Standardized Drug Labelling
Study First Received: November 1, 2010
Last Updated: September 7, 2011
Health Authority: Germany: Ethics Commission

Keywords provided by Charite University, Berlin, Germany:
drug labelling
standardized drug syringe labelling
European ICU

ClinicalTrials.gov processed this record on August 01, 2014